Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Glioblastoma | Research

Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status

Authors: Ke Wang, Yeming Li, Haiyang Cheng, Shenjie Li, Wei Xiang, Yang Ming, Ligang Chen, Jie Zhou

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

The aim of this study was to investigate the relationship between tumor biology and values of cerebral blood volume (CBV), cerebral blood flow (CBF), mean transit time (MTT), time to peak (TTP), permeability surface (PS) of tumor in patients with glioma.

Methods

Forty-six patients with glioma were involved in the study. Histopathologic and molecular pathology diagnoses were obtained by tumor resection, and all patients accepted perfusion computed tomography (PCT) before operation. Regions of interests were placed manually at tumor and contralateral normal-appearing thalamus. The parameters of tumor were divided by those of contralateral normal-appearing thalamus to normalize at tumor (relative [r] CBV, rCBF, rMTT, rTTP, rPS). The relationships of the parameters, world health organization (WHO) grade, molecular pathological findings were analysed.

Results

The rCBV, rMTT and rPS of patients are positively related to the pathological classification (P < 0.05). The values of rCBV and rPS in IDH mutated patients were lower than those IDH wild-type. The values of rCBF in patients with MGMT methylation were lower than those MGMT unmethylation (P < 0.05). The MVD of TERT wild-type group was lower than TERT mutated group (P < 0.05). The values of rCBV were significant difference in the four molecular groups divided by the combined IDH/TERT classification (P < 0.05). The progression free survival (PFS) and overall survival (OS) were significant difference in the four molecular groups divided by the combined IDH/TERT classification (P < 0.05).

Conclusions

Our study introduces and supports the changes of glioma flow perfusion may be closely related to its biological characteristics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stoecklein VM, Stoecklein S, Galiè F, Ren J, Schmutzer M, Unterraine M, et al. Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients. Neuro Oncol. 2020;22:1388–98.CrossRef Stoecklein VM, Stoecklein S, Galiè F, Ren J, Schmutzer M, Unterraine M, et al. Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients. Neuro Oncol. 2020;22:1388–98.CrossRef
2.
go back to reference Houillier C, Wang X, Kaloshi G, Mokhtari K, Guillevin R, Laffaire J, et al. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology. 2010;75:1560–6.CrossRef Houillier C, Wang X, Kaloshi G, Mokhtari K, Guillevin R, Laffaire J, et al. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology. 2010;75:1560–6.CrossRef
3.
go back to reference Zhang J, Yang J-H, Quan J, Kang X, Wang H-J, Dai P-G. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas. Tumour Biol. 2016;37:13571–9.CrossRef Zhang J, Yang J-H, Quan J, Kang X, Wang H-J, Dai P-G. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas. Tumour Biol. 2016;37:13571–9.CrossRef
4.
go back to reference Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. New Engl J Med. 2015;372:2499–508.CrossRef Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. New Engl J Med. 2015;372:2499–508.CrossRef
5.
go back to reference Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6:107–16.CrossRef Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6:107–16.CrossRef
6.
go back to reference Chahal M, Xu Y, Lesniak D, Graham K, Famulski K, Christensen JG, et al. MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. Neuro-Oncology. 2010;12:822–33.CrossRef Chahal M, Xu Y, Lesniak D, Graham K, Famulski K, Christensen JG, et al. MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. Neuro-Oncology. 2010;12:822–33.CrossRef
7.
go back to reference Simon M, Hosen I, Gousias K, Rachakonda S, Heidenreich B, Gessi M, et al. TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas. Neuro-Oncology. 2015;17:45–52.CrossRef Simon M, Hosen I, Gousias K, Rachakonda S, Heidenreich B, Gessi M, et al. TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas. Neuro-Oncology. 2015;17:45–52.CrossRef
8.
go back to reference Powter B, Jeffreys SA, Sareen H, Cooper A, Brungs D, Po J, et al. Human TERT promoter mutations as a prognostic biomarker in glioma. J Cancer Res Clin Oncol. 2021;147:1007–17.CrossRef Powter B, Jeffreys SA, Sareen H, Cooper A, Brungs D, Po J, et al. Human TERT promoter mutations as a prognostic biomarker in glioma. J Cancer Res Clin Oncol. 2021;147:1007–17.CrossRef
9.
go back to reference Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol. 2012;181:1126–41.CrossRef Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol. 2012;181:1126–41.CrossRef
10.
go back to reference Jain R, Griffith B, Alotaibi F, Zagzag D, Fine H, Golfinos J, et al. Glioma angiogenesis and perfusion imaging: understanding the relationship between tumor blood volume and leakiness with increasing glioma grade. AJNR Am J Neuroradiol. 2015;36:2030–5.CrossRef Jain R, Griffith B, Alotaibi F, Zagzag D, Fine H, Golfinos J, et al. Glioma angiogenesis and perfusion imaging: understanding the relationship between tumor blood volume and leakiness with increasing glioma grade. AJNR Am J Neuroradiol. 2015;36:2030–5.CrossRef
11.
go back to reference Ellika SK, Jain R, Patel SC, Scarpace L, Schultz LR, Rock JP, et al. Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol. 2007;28:1981–7.CrossRef Ellika SK, Jain R, Patel SC, Scarpace L, Schultz LR, Rock JP, et al. Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol. 2007;28:1981–7.CrossRef
12.
go back to reference Ahmad N, Shaukat A, Rehan A, Rashid S. Diagnostic accuracy of perfusion computed tomography in cerebral glioma grading. J Coll Physicians Surg Pak. 2016;26:562–5.PubMed Ahmad N, Shaukat A, Rehan A, Rashid S. Diagnostic accuracy of perfusion computed tomography in cerebral glioma grading. J Coll Physicians Surg Pak. 2016;26:562–5.PubMed
13.
go back to reference Karegowda LH, Kadavigere R, Shenoy PM, Paruthikunnan SM. Efficacy of Perfusion Computed Tomography (PCT) in Differentiating High-Grade Gliomas from Low Grade Gliomas, Lymphomas, Metastases and Abscess. J Clin Diagn Res. 2017;11:TC28–33.CrossRef Karegowda LH, Kadavigere R, Shenoy PM, Paruthikunnan SM. Efficacy of Perfusion Computed Tomography (PCT) in Differentiating High-Grade Gliomas from Low Grade Gliomas, Lymphomas, Metastases and Abscess. J Clin Diagn Res. 2017;11:TC28–33.CrossRef
14.
go back to reference Kaichi Y, Tatsugami F, Nakamura Y, Baba Y, Iida M, Higaki T, et al. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT. Medicine (Baltimore). 2018;97:e11670.CrossRef Kaichi Y, Tatsugami F, Nakamura Y, Baba Y, Iida M, Higaki T, et al. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT. Medicine (Baltimore). 2018;97:e11670.CrossRef
15.
go back to reference Onishi S, Kajiwara Y, Takayasu T, Kolakshyapati M, Ishifuro M, Amatya VJ, et al. Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis. World Neurosurg. 2018;119:e890–7.CrossRef Onishi S, Kajiwara Y, Takayasu T, Kolakshyapati M, Ishifuro M, Amatya VJ, et al. Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis. World Neurosurg. 2018;119:e890–7.CrossRef
16.
go back to reference Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, et al. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol. 2018;139:805–10.CrossRef Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, et al. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol. 2018;139:805–10.CrossRef
17.
go back to reference Yang P, Cai J, Yan W, Zhang W, Wang Y, Chen B, et al. Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas. Neuro-Oncology. 2016;18:1099–108.CrossRef Yang P, Cai J, Yan W, Zhang W, Wang Y, Chen B, et al. Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas. Neuro-Oncology. 2016;18:1099–108.CrossRef
18.
go back to reference Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, et al. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016;4:79.CrossRef Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, et al. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016;4:79.CrossRef
19.
go back to reference Narang J, Jain R, Scarpace L, Saksena S, Schultz LR, Rock JP, et al. Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors. J Neuro-Oncol. 2011;102:287–93.CrossRef Narang J, Jain R, Scarpace L, Saksena S, Schultz LR, Rock JP, et al. Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors. J Neuro-Oncol. 2011;102:287–93.CrossRef
20.
go back to reference Shankar JJS, Woulfe J, Da Silva V, Nguyen TB. Evaluation of perfusion CT in grading and prognostication of high-grade gliomas at diagnosis: a pilot study. AJR Am J Roentgenol. 2013;200:W504–9.CrossRef Shankar JJS, Woulfe J, Da Silva V, Nguyen TB. Evaluation of perfusion CT in grading and prognostication of high-grade gliomas at diagnosis: a pilot study. AJR Am J Roentgenol. 2013;200:W504–9.CrossRef
21.
go back to reference Kickingereder P, Sahm F, Radbruch A, Wick W, Heiland S, von Deimling A, et al. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma. Sci Rep. 2015;5:16238.CrossRef Kickingereder P, Sahm F, Radbruch A, Wick W, Heiland S, von Deimling A, et al. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma. Sci Rep. 2015;5:16238.CrossRef
22.
go back to reference Fainardi E, Di Biase F, Borrelli M, Saletti A, Cavallo M, Sarubbo S, et al. Potential role of CT perfusion parameters in the identification of solitary intra-axial brain tumor grading. Acta Neurochir Suppl. 2010;106:283–7.CrossRef Fainardi E, Di Biase F, Borrelli M, Saletti A, Cavallo M, Sarubbo S, et al. Potential role of CT perfusion parameters in the identification of solitary intra-axial brain tumor grading. Acta Neurochir Suppl. 2010;106:283–7.CrossRef
23.
go back to reference Chai R, Li G, Liu Y, Zhang K, Zheng Z, Wu F, et al. Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma. Cancer Biol Med. 2021;18:272–82.CrossRef Chai R, Li G, Liu Y, Zhang K, Zheng Z, Wu F, et al. Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma. Cancer Biol Med. 2021;18:272–82.CrossRef
24.
go back to reference Jain R, Ellika SK, Scarpace L, Schultz LR, Rock JP, Gutierrez J, et al. Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. AJNR Am J Neuroradiol. 2008;29:694–700.CrossRef Jain R, Ellika SK, Scarpace L, Schultz LR, Rock JP, Gutierrez J, et al. Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. AJNR Am J Neuroradiol. 2008;29:694–700.CrossRef
25.
go back to reference Zimny A, Leszek J, Kiejna A, Sasiadek M. Analysis of correlation between the degree of cognitive impairment and the results of perfusion CT in patients with dementia. Med Sci Monit. 2007;13(Suppl 1):23–30.PubMed Zimny A, Leszek J, Kiejna A, Sasiadek M. Analysis of correlation between the degree of cognitive impairment and the results of perfusion CT in patients with dementia. Med Sci Monit. 2007;13(Suppl 1):23–30.PubMed
26.
go back to reference Grand S, Tahon F, Attye A, Lefournier V, Le Bas J-F, Krainik A. Perfusion imaging in brain disease. Diagn Interv Imaging. 2013;94:1241–57.CrossRef Grand S, Tahon F, Attye A, Lefournier V, Le Bas J-F, Krainik A. Perfusion imaging in brain disease. Diagn Interv Imaging. 2013;94:1241–57.CrossRef
27.
go back to reference Chesnelong C, Chaumeil MM, Blough MD, Al-Najjar M, Stechishin OD, Chan JA, et al. Lactate dehydrogenase a silencing in IDH mutant gliomas. Neuro-Oncology. 2014;16:686–95.CrossRef Chesnelong C, Chaumeil MM, Blough MD, Al-Najjar M, Stechishin OD, Chan JA, et al. Lactate dehydrogenase a silencing in IDH mutant gliomas. Neuro-Oncology. 2014;16:686–95.CrossRef
28.
go back to reference Ahn SS, Shin N-Y, Chang JH, Kim SH, Kim EH, Kim DW, et al. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging. J Neurosurg. 2014;121:367–73.CrossRef Ahn SS, Shin N-Y, Chang JH, Kim SH, Kim EH, Kim DW, et al. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging. J Neurosurg. 2014;121:367–73.CrossRef
29.
go back to reference Jain R, Gutierrez J, Narang J, Scarpace L, Schultz LR, Lemke N, et al. In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas. AJNR Am J Neuroradiol. 2011;32:388–94.CrossRef Jain R, Gutierrez J, Narang J, Scarpace L, Schultz LR, Lemke N, et al. In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas. AJNR Am J Neuroradiol. 2011;32:388–94.CrossRef
Metadata
Title
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
Authors
Ke Wang
Yeming Li
Haiyang Cheng
Shenjie Li
Wei Xiang
Yang Ming
Ligang Chen
Jie Zhou
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02490-4

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue